Supernus Pharmaceuticals
SUPN
#4153
Rank
NZ$4.95 B
Marketcap
NZ$86.05
Share price
0.20%
Change (1 day)
67.08%
Change (1 year)

Supernus Pharmaceuticals (SUPN) - Total liabilities

Total liabilities on the balance sheet as of December 2025 : NZ$0.66 Billion

According to Supernus Pharmaceuticals 's latest financial reports the company's total liabilities are NZ$0.66 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Supernus Pharmaceuticals - Total liabilities on balance sheet (from 2009 to 2025)

Total liabilities by year

Year Total liabilities Change
2025-12-31NZ$0.67 B14.55%
2024-12-31NZ$0.58 B4.63%
2023-12-31NZ$0.56 B-56.2%
2022-12-31NZ$1.28 B0.56%
2021-12-31NZ$1.27 B21.51%
2020-12-31NZ$1.05 B25.46%
2019-12-31NZ$0.83 B7.2%
2018-12-31NZ$0.78 B253.94%
2017-12-31NZ$0.22 B29.96%
2016-12-31NZ$0.17 B15.69%
2015-12-31NZ$0.14 B19.88%
2014-12-31NZ$0.12 B29.98%
2013-12-31NZ$94.34 M113.11%
2012-12-31NZ$44.27 M-21.98%
2011-12-31NZ$56.74 M-52.07%
2010-12-31NZ$0.11 B-0.08%
2009-12-31NZ$0.11 B-18.03%
2008-12-31NZ$0.14 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Johnson & Johnson
JNJ
NZ$200.93 B 29,998.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$57.96 B 8,582.28%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$146.76 B 21,883.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$122.15 B 18,197.72%๐Ÿ‡บ๐Ÿ‡ธ USA
United Therapeutics
UTHR
NZ$1.33 B 100.49%๐Ÿ‡บ๐Ÿ‡ธ USA